Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Category: Portfolio News

Portfolio News

SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases

Portfolio News

Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure

Portfolio News

Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular

Portfolio News

CVRx® Raises $50 Million in New Equity Financing

Portfolio News

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

Portfolio News

Two medical device makers in Wayne get big boosts

Portfolio News

Wayne medical device developer and its spin-off reel in $62 million

Portfolio News

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System™

Portfolio News

Intact Vascular Announces $25 Million Financing with Vensana Capital to Drive Commercialization of the Tack Endovascular System®

Portfolio News

Intact Vascular, Vesper Medical Raise Capital to Tackle Blood-Vessel Diseases

17

Novel FDA PMA & de novo 510k approvals

37

U.S. Commercial Product Launches

34

Level I Clinical Trials

23

Strategic Financings

25

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠

Ready to change healthcare together?

Get in Touch

Our Latest

See All News
SpyGlass Ophthalmics Completes $27.5 Million Series B Financing to Advance Novel Treatments for Chronic Ophthalmic Diseases
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
Philips to expand its image-guided therapy devices portfolio through acquisition of Intact Vascular
Resources
News LP Access
Contact
info@vensanacap.com 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 101 Church Street Suite D Vienna, VA 22180

© 2019 Vensana Capital Management, LLC | Privacy | Terms & Conditions